All stock lists
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
Healthcare · Drug Manufacturers - Specialty & Generic
26.79-0.41 (-1.51%)
Insider Score
––Not scored
AMLX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AMLX analyst forecast
AMLX analyst consensus
No analyst ratings in the last 3 months.
AMLX 12-month price target
$51.33+90.6% upsideaverage of 3 firms
$57.00High
$42.00Low
Best analysts covering AMLX
No firm covering AMLX has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AMLX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Guggenheim | — | $57.00 | +53.7% | — | 2026-08-27 | |
| Mizuho Securities | — | $42.00 | +19.6% | — | 2026-08-18 | |
| H.C. Wainwright | — | $55.00 | +56.7% | — | 2026-08-18 | |
| Mizuho Securities | — | $30.00 | +38.7% | — | 2026-08-17 | |
| Mizuho Securities | — | $24.00 | +35.2% | — | 2026-07-20 | |
| H.C. Wainwright | — | $34.00 | +155.3% | — | 2026-06-08 | |
| Mizuho Securities | — | $21.00 | +24.4% | — | 2026-04-28 | |
| H.C. Wainwright | — | $28.00 | +96.9% | — | 2026-02-10 | |
| Robert W. Baird | — | $19.00 | +20.3% | — | 2025-10-16 | |
| Guggenheim | — | $25.00 | +111.0% | — | 2025-09-15 | |
| Guggenheim | — | $17.00 | +165.2% | — | 2025-06-24 | |
| Leerink Partners | — | $10.00 | +115.1% | — | 2025-05-06 | |
| Robert W. Baird | — | $11.00 | +131.1% | — | 2024-11-18 | |
| Bank of America Securities | — | $10.00 | +120.8% | — | 2024-10-23 | |
| H.C. Wainwright | — | $8.00 | +104.1% | — | 2024-10-18 | |
| Leerink Partners | — | $4.00 | +2.0% | — | 2024-10-18 | |
| Mizuho Securities | — | $3.00 | +64.8% | — | 2024-05-14 | |
| Robert W. Baird | — | $3.00 | +22.0% | — | 2024-04-11 | |
| Deutsche Bank | — | $4.00 | +53.0% | — | 2024-04-04 | |
| Mizuho Securities | — | $4.00 | +23.5% | — | 2024-03-17 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.